VIII Use of Alprenolol in the Secondary Prevention of Myocardial Infarction

Paulette Mehta, Jawahar Mehta, Platelet function studies in coronary artery disease. V. Evidence for enhanced platelet microthrombus formation activity in acute myocardial infarction. American Journal of Cardiology. ,vol. 43, pp. 757- 760 ,(1979) , 10.1016/0002-9149(79)90075-4

David Sparrow, Thomas R. Dawber, Theodore Colton, The influence of cigarette smoking on prognosis after a first myocardial infarction Journal of Chronic Diseases. ,vol. 31, pp. 425- 432 ,(1978) , 10.1016/0021-9681(78)90006-1

W. G. NAYLER, A. GRAU, C. YEPEZ, β-adrenoceptor antagonists and the release of creatine phosphokinase from hypoxic heart muscle Cardiovascular Research. ,vol. 11, pp. 344- 352 ,(1977) , 10.1093/CVR/11.4.344

J T Salonen, Stopping smoking and long-term mortality after acute myocardial infarction. Heart. ,vol. 43, pp. 463- 469 ,(1980) , 10.1136/HRT.43.4.463

P. LIBBY, P. R. MAROKO, J. W. COVELL, C. I. MALLOCH, J. ROSS, E. BRAUNWALD, Effect of practolol on the extent of myocardial ischaemic injury after experimental coronary occlusion and its effects on ventricular function in the normal and ischaemic heart Cardiovascular Research. ,vol. 7, pp. 167- 173 ,(1973) , 10.1093/CVR/7.2.167

JAMES W. COVELL, JOHN ROSS, EUGENE BRAUNWALD, PETER R. MAROKO, JOHN K. KJEKSHUS, BURTON E. SOBEL, TAN WATANABE, Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions Circulation. ,vol. 43, pp. 67- 82 ,(1971) , 10.1161/01.CIR.43.1.67

S. H. Taylor, B. Silke, A. Ebbutt, G. C. Sutton, B. J. Prout, D. M. Burley, A long-term prevention study with oxprenolol in coronary heart disease. The New England Journal of Medicine. ,vol. 307, pp. 1293- 1301 ,(1982) , 10.1056/NEJM198211183072101

MogensP Andersen, Jens Frederiksen, HansJ Jürgensen, Flemming Pedersen, Peter Bechsgaard, DanA Hansen, Bo Nielsen, Ole Pedersen-Bjergaard, SørenL Rasmussen, EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTION: Preliminary Results The Lancet. ,vol. 314, pp. 865- 868 ,(1979) , 10.1016/S0140-6736(79)92684-9

V Hansteen, E Moinichen, E Lorentsen, A Andersen, O Strom, K Soiland, D Dyrbekk, A M Refsum, A Tromsdal, K Knudsen, C Eika, J Bakken, P Smith, P I Hoff, One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. BMJ. ,vol. 284, pp. 155- 160 ,(1982) , 10.1136/BMJ.284.6310.155

Å. Hjalmarson, J. Herlitz, I. Málek, L. Rydén, A. Vedin, A. Waldenström, H. Wedel, D. Elmfeldt, S. Holmberg, G. Nyberg, K. Swedberg, F. Waagstein, J. Waldenström, L. Wilhelmsen, C. Wilhelmsson, Effect on mortality of metoprolol in acute myocardial infarction The Lancet. ,vol. 318, pp. 823- 827 ,(1981) , 10.1016/S0140-6736(81)91101-6